Randolph Co Inc: MRK position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Randolph Co Inc on MRK, newest first. How the timeline and the estimate are built.
Randolph Co Inc held 0 MRK shares at 2025-12-31 per its 13F-HR filed 2026-02-11.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -4,123 shares
13F-HR 0002085853-26-000239 filed by Randolph Co Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 4,123 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $346,058.
13F-HR 0002085853-25-000168 filed by Randolph Co Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 4,123 sharesChange vs previous 13F -201,104 shares
0.03% of the 13F portfolio, value $326,391.
13F-HR 0001667731-25-000837 filed by Randolph Co Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 205,227 sharesChange vs previous 13F -843 shares
2.16% of the 13F portfolio, value $18,421,214.
13F-HR 0001667731-25-000430 filed by Randolph Co Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 206,070 sharesChange vs previous 13F +1,049 shares
2.29% of the 13F portfolio, value $20,499,844.
13F-HR 0001667731-25-000279 filed by Randolph Co Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 205,021 sharesChange vs previous 13F not available
2.71% of the 13F portfolio, value $23,282,185.
13F-HR 0001475150-24-000005 filed by Randolph Co Inc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).